A federal crackdown on the black-market trade of opioids in the United States increases compliance-related risks for financial institutions that maintain accounts for chemical manufacturers and distributors, say sources.
Bankers and other financial services professionals have a role to play in tackling the epidemic of prescription-based opioid abuse in the United States, current and former law enforcement officials say.
Wealthy Chinese nationals are buying illicit U.S. dollars from Latin American drug traffickers to skirt their country’s increasingly strict controls against capital flight, say sources.